AHNAK2 and hepatocellular carcinoma: A study collected 39 specimens of HCC patients from China, 22 of which were subjected to whole exome sequencing, and revealed a high mutation rate in AHNAK2 (22.7%, 5/22), although the high mutation rate in AHNAK2 was not explored in more detail (81).